C7A.023

Clinical Causes: Genetic mutations affecting neuroendocrine cells Family history of similar tumors or other types of cancer Age-related cellular changes, typically occurring in middle-aged or older adults Certain inherited syndromes such as Multiple Endocrine Neoplasia (MEN)

Key Symptoms: Abdominal pain or discomfort Changes in bowel habits, such as diarrhea or constipation Unexplained weight loss A sensation of fullness or bloating in the abdomen Possible signs of blockage or obstruction in the colon Rarely, symptoms related to hormone secretion by the tumor, such as flushing or diarrhea

Diagnosis Path: Diagnosing a malignant carcinoid tumor of the transverse colon involves various tests to confirm its presence and extent: - Colonoscopy with biopsy to examine tissue samples - Imaging studies such as CT scans, MRI, or somatostatin receptor scintigraphy (e.g., Octreoscan) to locate tumors and assess spread - Blood and urine tests to measure markers like chromogranin A, which may be elevated - Histopathological examination to determine tumor type and malignancy level - Additional assessments might include PET scans to detect metastasis

Treatment Protocols: Managing a malignant carcinoid tumor typically involves a multidisciplinary approach: - Surgical removal of the tumor, often through colectomy (removal of part of the colon) - Additional procedures depending on tumor size and spread, such as lymph node removal - If the tumor secretes hormones causing symptoms, medical therapies like somatostatin analogs (e.g., octreotide) may be used to control hormone-related issues - Targeted therapies or chemotherapy in cases where the tumor has metastasized - Regular follow-up with imaging and blood tests to monitor for recurrence or spread - Supportive care to manage symptoms and improve quality of life